title: Neuropharmacological aspects of cognitive neurorehabilitation in epilepsy.
abstract: The role of CNS neuromodulators in cognitive neurorehabilitation can be related to two main issues: 1) the negative impact on cognition of drug categories prescribed for different neurologic symptoms, such as spasticity, extrapyramidal symptoms, or epileptic seizures; 2) their possible role in neuroprotection and amelioration of the cognitive status of the patient, especially attention and memory. This paper reviews different pharmacological aspects of cognitive neurorehabilitation in epilepsy.
authors.affiliation: Department of Neurology, Amedeo Avogadro University, Novara, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Mula
authors.forename: Michael R
authors.initials: MR
authors.lastname: Trimble
mesh_terms: D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000534:rehabilitation; D015928:Cognitive Behavioral Therapy / Q000379:methods; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D018696:Neuroprotective Agents; D018377:Neurotransmitter Agents; D018697:Nootropic Agents